Vigano Paul R: insider trades.
Vigano Paul R reported 9 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($216.7M), across 1 company.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 9
- Companies
- 1
- Name as filed
- VIGANO PAUL R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Aveanna Healthcare Holdings, Inc. (AVAH) | TenPercentOwner | 9 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-21 | Aveanna Healthcare Holdings, Inc. | S | 2,250,000 | $11.5 | 12,315,892 | Form 4 |
| 2026-08-20 | Aveanna Healthcare Holdings, Inc. | S | 190,130 | $11.5 | 0 | Form 4 |
| 2026-08-20 | Aveanna Healthcare Holdings, Inc. | S | 1,426,034 | $11.5 | 0 | Form 4 |
| 2026-08-20 | Aveanna Healthcare Holdings, Inc. | S | 1,813,795 | $11.5 | 0 | Form 4 |
| 2026-08-20 | Aveanna Healthcare Holdings, Inc. | S | 957,918 | $11.5 | 14,565,892 | Form 4 |
| 2026-08-20 | Aveanna Healthcare Holdings, Inc. | S | 10,112,125 | $11.5 | 0 | Form 4 |
| 2026-06-30 | Aveanna Healthcare Holdings, Inc. | S | 2,419,035 | $8.01 | 10,112,123 | Form 4 |
| 2026-06-30 | Aveanna Healthcare Holdings, Inc. | S | 525,844 | $8.01 | 1,813,795 | Form 4 |
| 2026-06-30 | Aveanna Healthcare Holdings, Inc. | S | 55,121 | $8.01 | 190,130 | Form 4 |
Questions
What stock did Vigano Paul R buy or sell?
Vigano Paul R reported 9 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($216.7M), across 1 company.
Is Vigano Paul R the same person as other filers with this name?
This page covers SEC CIK 1239606 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/vigano-paul-r-1239606.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.